UNC Chapel Hill researcher to reveal results of study of aspirins effects on colon polyps

News Conference
Wednesday, March 5, 2:45 p.m.
Bioinformatics Building, UNC Medical Campus

Results of a major national study of the effects of aspirin on the recurrence of intestinal polyps, often considered a precursor to colorectal cancer, will be announced Wednesday (March 5) at a news conference at the University of North Carolina at Chapel Hill School of Medicine. The briefing will begin at 2:45 p.m. in Room 4137 of the Bioinformatics Building. Note: This story is embargoed until 5 p.m. EST Wednesday in keeping with the embargo established by the New England Journal of Medicine, which will publish the findings Thursday.

Dr. Robert Sandler, professor of medicine, will describe the study for which he was overall principal investigator. Sandler also directs UNC's Center for Gastrointestinal Biology and Disease. More than 100 U.S. medical centers and clinics participated.

Reporters can park in the Dogwood Parking Deck off Manning Drive across from UNC Hospitals. Videographers can unload equipment in front of the Bioinformatics Bldg., which immediately south of the Cardinal (employee) Parking Deck at the corner of Mason Farm Road and West Drive, before moving vehicles to the Dogwood Parking Deck. After exiting the elevators on the 4th Floor of the Bioinformatics Bldg., turn left and follow the signs to Room 4137, which is the UNC Center for Gastrointestinal Biology and Disease's Conference Room.


Contact: David Williamson
University of North Carolina at Chapel Hill

Page: 1

Related biology news :

1. New DVD virtual microscope at UNC-Chapel Hill
2. UNC-Chapel Hill gene therapy center awarded $9.2 million from NIH
3. University Of North Carolina At Chapel Hill Scientists Find Breast Cancer Gene Required To Correct Certain GeneticDamage
4. Belgian researchers explore revolutionary approach to angiogenesis
5. Award winning researchers reveal potential new role for Glivec
6. University of Alberta researcher looks for clues to mysterious disease
7. $7.5 Million grant to Yale researchers for role of viruses in cancer
8. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
9. Joslin researchers clarify mechanisms for beta-cell formation
10. Pioneering AIDS researcher to speak at UH
11. Defensive action by influenza viruses demonstrated by Hebrew university researcher

Post Your Comments:

(Date:8/21/2020)... , ... August 20, 2020 , ... ... Hassan Movahhed , a Clinical Operations executive with expertise in clinical trial ... joined the firm as an Expert Consultant. Throughout his career, Mr. Movahhed has ...
(Date:8/5/2020)... ... 2020 , ... Regenative Labs has received approval from the Centers for Medicare ... the first Wharton’s jelly allografts to be assigned a Q code and be approved ... first Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS ...
(Date:7/18/2020)... ... 16, 2020 , ... A study has been published in ... active noise control device to attenuate typical noises in a simulated neonatal intensive ... alarm sounds from patient monitors, ventilators and other bedside devices that would affect ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... August 03, 2020 , ... ... Jim Corrigan, President and CEO has been named one of the 100 most ... industry sectors, PharmaVoice 100 honorees are selected based on how they have inspired ...
(Date:7/31/2020)... ... 29, 2020 , ... R3 Stem Cell International is now offering patients the ... stem cells total, patients may choose which extremities they would like treated. , Several ... Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... radar transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and ... can drive one or two switches in a push-pull configuration; yielding fast fall ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. ... of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and ... a strategic partnership whereby Catalent will provide support for the development, manufacturing, and ...
Breaking Biology Technology:
Cached News: